Pages that link to "Q423762"
Jump to navigation
Jump to search
The following pages link to paclitaxel (Q423762):
Displaying 50 items.
- carcinoma (Q33525) (← links)
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- breast cancer (Q128581) (← links)
- ovarian cancer (Q172341) (← links)
- melanoma (Q180614) (← links)
- nuclear receptor subfamily 1 group I member 2 (Q409867) (← links)
- amiodarone (Q410061) (← links)
- phenytoin (Q410400) (← links)
- trimethoprim (Q422665) (← links)
- Kaposi's sarcoma (Q725345) (← links)
- invasive ductal carcinoma (Q1671685) (← links)
- Taxus brevifolia (Q2065540) (← links)
- non-small-cell lung carcinoma (Q3658562) (← links)
- crizotinib (Q5186964) (← links)
- fosphenytoin (Q5473363) (← links)
- squamous cell carcinoma of the lung (Q5749020) (← links)
- idelalisib (Q5908266) (← links)
- paclitaxel total synthesis (Q7123071) (← links)
- protein-bound paclitaxel (Q7251413) (← links)
- Taxol, Carboplatin and Herceptin (Q7689671) (← links)
- (Q12438676) (redirect page) (← links)
- (Q12968995) (redirect page) (← links)
- Toll-like receptor 4 (Q14914104) (← links)
- head and neck squamous cell carcinoma (Q18348812) (← links)
- lung benign neoplasm (Q18556020) (← links)
- gastric adenocarcinoma (Q18556047) (← links)
- pancreatic adenocarcinoma (Q18556189) (← links)
- metastatic melanoma (Q18975855) (← links)
- Tubulin beta class I (Q21114332) (← links)
- Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer (Q21134780) (← links)
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity (Q21245463) (← links)
- KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells (Q21245466) (← links)
- paclitaxel biosynthetic process (Q22278104) (← links)
- Jos Beijnen (Q23771643) (← links)
- Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment (Q23914149) (← links)
- Detection and measurement of surface contamination by multiple antineoplastic drugs using multiplex bead assay (Q23914798) (← links)
- Development of an HPLC method for simultaneous analysis of five antineoplastic agents (Q23920413) (← links)
- A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents (Q23920414) (← links)
- Monitoring method for surface contamination caused by selected antineoplastic agents (Q23923245) (← links)
- Ototoxicity of paclitaxel in rat cochlear organotypic cultures (Q23924012) (← links)
- Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction (Q23924046) (← links)
- Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancer (Q24187365) (← links)
- Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma (Q24234425) (← links)
- RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1 (Q24273390) (← links)
- Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) (Q24289538) (← links)
- Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel (Q24298654) (← links)
- Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells (Q24317614) (← links)
- Synergistic interaction of lovastatin and paclitaxel in human cancer cells (Q24323696) (← links)
- Repeat motifs of tau bind to the insides of microtubules in the absence of taxol (Q24540276) (← links)
- Taxol biosynthesis: taxane 13 alpha-hydroxylase is a cytochrome P450-dependent monooxygenase (Q24555092) (← links)